[En-bloc laser resection of the urinary bladder tumor].

Urologiia

Research Institute for Uronephrology and Human Reproductive Health, Department and Clinic of Urology, I.M. Sechenov First MSMU, Moscow, Russia.

Published: May 2018

Currently, transurethral resection of a bladder tumor (TUR) is the gold standart treatment for non-muscle invasive bladder cancer (NMIBC). Standard TUR for a bladder wall tumor has a high recurrence rate, which is caused mainly by malignant cell implantation during the surgery. Besides, specimens obtained with conventional TUR are insufficient for accurate pathological staging. The non-conformity of the standard TUR with the established oncological principle of dissecting through normal tissue prompted a search for the optimal surgical modality. En-bloc resection of the bladder wall tumor has been proposed as an alternative method for surgical management of NMIBC. This technique involves the resection of bladder tumor through the underlying muscle layer as a single piece thus providing high quality material for subsequent morphological study and reducing the risk of metastasizing by implantation of malignant cells. This paper presents an analysis of relevant research literature published in the last twenty years, describes all currently existing techniques of the bladder tumor resection using a variety of energy sources, including laser.

Download full-text PDF

Source

Publication Analysis

Top Keywords

resection bladder
12
bladder tumor
12
standard tur
8
bladder wall
8
wall tumor
8
bladder
7
resection
5
tumor
5
[en-bloc laser
4
laser resection
4

Similar Publications

Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms.

Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients' International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The review discusses current treatment methods and strategies for managing lower urinary tract symptoms (LUTS) linked to treatments like transurethral resection and intravesical therapy.
  • Recent findings highlight that while there's limited research, some oral agents and new therapies show promise in alleviating LUTS associated with intravesical treatments, such as phenazopyridine and beta-3 agonists.
  • The review emphasizes the need for more research to validate these treatments and to develop effective strategies for managing LUTS in patients undergoing various intravesical therapy regimens.
View Article and Find Full Text PDF

Nephrogenic adenoma of the urinary bladder is a rare, benign lesion associated with prior inflammation or irritation of the urothelium. Although typically benign, nephrogenic adenoma can present diagnostic challenges due to its potential to mimic malignant tumors of the urinary tract. In this report, we present a case of an elderly woman with a history of recurrent urinary tract infections and bladder stone surgery who developed nephrogenic adenoma.

View Article and Find Full Text PDF
Article Synopsis
  • Localized bladder amyloidosis is a rare condition that can be mistaken for a bladder tumor, with only over 200 cases documented.
  • A 67-year-old woman experienced painless blood in urine, leading to tests that suggested bladder amyloidosis, including a Congo red staining potentially indicating the presence of amyloid.
  • The excised tissue from her procedure showed unexpected pink-staining patterns but did not confirm amyloidosis through Congo red staining, highlighting the importance of thorough evaluation for diagnosis despite negative results.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!